199O A phase II study investigating neoadjuvant atezolizumab in cisplatin-ineligible patients with muscle-invasive bladder cancer: Final analysis. - Szabados, B.E.; Rodriguez-Vida, A.; Duran, I.; Crabb, S.J.; van der Heijden, M.S.; Pous, A. Font; Gravis, G.; Herranz, U. Anido; Protheroe, A.; Ravaud, A.; Maillet, D.; Mendez, M.J.; et al. (Annals of Oncology, 2020)